Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year. - 2Before trips to Mars, we need better protection from cosmic rays
- 3How did I get my own unique set of fingerprints?
- 4Irish defence minister's trip to Lebanon cancelled
- 5The Most Notable Design Brands of the 21st Hundred years
- I watched more than 500 new movies this year. These are the 25 best ones.
- Amplifying Cash The executives: The Upsides and downsides of Various Ledgers
- Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- These four astronauts could soon travel farther from Earth than anyone has gone before
- Instructions to Warmly greet Certainty and Appeal
- Windows to the Previous: An Excursion Through the World's Notable Engineering
- Ukraine's naval drones are gunning for Russia's 'shadow fleet.' A security source says a tanker just suffered a critical hit.
- Broken toilet, T-shirts on windows and collecting saliva: The weirdness of daily life aboard Orion
- Are protests pushing Iran's Islamic regime toward a tipping point?
